Results 171 to 180 of about 45,542 (206)

Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy. [PDF]

Acta Oncol
Molin D.
europepmc   +1 more source

Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I Study. [PDF]

Cancers (Basel)
Joffe E, Epstein-Peterson Z, Falchi L, Noy A, Zelenetz AD, Owens C, Gilbert L, Salles G, Soff GA.   +8 more
europepmc   +1 more source

Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study. [PDF]

Br J Haematol
Trab T, Ranadóttir T, Chanchiri I, Ludvigsen Al-Mashhadi A, Berggreen Dall E, Rasch S, Johansen M, Haunstrup LM, Cunsolo G, Poulsen CB, Larsen TS, Husby S, Brown P, Hawkes EA, El-Galaly TC, Grønbæk K.   +15 more
europepmc   +1 more source

"B" symptoms and CBV conditioning negatively impact survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation. [PDF]

Ann Hematol
Chromik K, Wieczorkiewicz-Kabut A, Zielińska P, Koclęga A, Kadłubek S, Kamiński J, Helbig G.   +6 more
europepmc   +1 more source

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial. [PDF]

Leukemia
Moia R, Ragaini S, Cascione L, Rinaldi A, Genuardi E, Talotta D, Almasri M, Bruscaggin A, Zaccaria GM, Evangelista A, Civita AM, Di Rocco A, Petrucci L, Cavallo F, Celli M, Luppi M, Stelitano C, Stefani PM, Visco C, Billio A, Casaroli I, Castellino C, Pavone E, Galimberti S, Plenteda C, Merli F, Mahmoud AM, Rossi D, Gaidano G, Ladetto M, Bertoni F, Ferrero S.   +31 more
europepmc   +1 more source

Thrombotic microangiopathy associated with mantle cell lymphoma: a case report. [PDF]

BMC Nephrol
Tonouchi Y, Hashimoto K, Iwabuchi R, Sakai H, Nimura T, Yamaka K, Nishikawa M, Yamaguchi A, Sonoda K, Kamijo Y.   +9 more
europepmc   +1 more source

Two B or not two B; the question of bendamustine dosing in low grade lymphoma. [PDF]

Pathol Oncol Res
Földi E, Wiedemann Á, Svorenj S, Szita VR, Tóth AD, Tárkányi I, Fehér Á, Kárpáti Á, Horváth L, Szombath G, Nagy Z, Bodó I, Farkas P, Masszi T, Varga G.   +14 more
europepmc   +1 more source

Hyperenhancing paravertebral mass in an adolescent: A rare presentation of unicentric Castleman disease. [PDF]

Radiol Case Rep
Magloire C, Navarro R, Tarasova A, Podberezin M, Model L, Derman A.   +5 more
europepmc   +1 more source